Find a Clinical Trial
Filter
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Relapsed or refractory myeloma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
M23-362
Diffuse large B-cell lymphoma, Follicular lymphoma, Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
HGB-210
Sickle cell anemia
All genders
2-50
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
75+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
ANHL1931
Lymphoma
All genders
2+
Recruiting now
Department of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Cancer Center
A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727
Acute myeloid leukemia (AML)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
CAR-T detection by IVFC
Lymphoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Multi-spectral imaging
Ovarian cancer
Female
18-99
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
PBCAR0191
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center